{{Rsnum
|rsid=3820185
|Gene=PLA2G4A
|Chromosome=1
|position=186839211
|Orientation=minus
|GMAF=0.4298
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=PLA2G4A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 8.0 | 42.5 | 49.6
| HCB | 38.7 | 42.3 | 19.0
| JPT | 23.9 | 46.9 | 29.2
| YRI | 12.2 | 51.7 | 36.1
| ASW | 19.3 | 36.8 | 43.9
| CHB | 38.7 | 42.3 | 19.0
| CHD | 39.4 | 48.6 | 11.9
| GIH | 6.9 | 38.6 | 54.5
| LWK | 20.9 | 47.3 | 31.8
| MEX | 15.5 | 46.6 | 37.9
| MKK | 16.0 | 48.7 | 35.3
| TSI | 14.7 | 42.2 | 43.1
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19795129
|Title=Impact of group IVA cytosolic phospholipase A2 gene polymorphisms on phenotypic features of patients with familial adenomatous polyposis
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}